Cytek Biosciences, Inc. (CTKB)
4.71
+0.09
(+1.95%)
USD |
NASDAQ |
Sep 09, 14:53
Cytek Biosciences Total Liabilities (Quarterly) : 124.98M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 124.98M |
| March 31, 2026 | 121.47M |
| December 31, 2025 | 119.80M |
| September 30, 2025 | 116.35M |
| June 30, 2025 | 115.76M |
| March 31, 2025 | 102.97M |
| December 31, 2024 | 106.34M |
| September 30, 2024 | 105.76M |
| June 30, 2024 | 94.60M |
| March 31, 2024 | 99.45M |
| December 31, 2023 | 104.60M |
| September 30, 2023 | 103.91M |
| Date | Value |
|---|---|
| June 30, 2023 | 100.88M |
| March 31, 2023 | 101.12M |
| December 31, 2022 | 97.98M |
| September 30, 2022 | 82.79M |
| June 30, 2022 | 81.69M |
| March 31, 2022 | 78.44M |
| December 31, 2021 | 58.70M |
| September 30, 2021 | 51.12M |
| June 30, 2021 | 46.94M |
| March 31, 2021 | 44.70M |
| December 31, 2020 | 42.09M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 6.604B |
| Bio-Rad Laboratories, Inc. | 3.078B |
| Bruker Corp. | 3.617B |
| Danaher Corp. | 39.78B |
| Harvard Bioscience, Inc. | 68.87M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 446.93M |
| Shareholders Equity (Quarterly) | 321.95M |
| Debt to Equity Ratio | 0.1093 |
| Current Ratio | 4.481 |
| Net Debt Paydown Yield | -0.30% |